Probiotics for Anxiety and Depression: Side by Side with an Antidepressant
Official title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Efficacy and Safety of Probiotics in Participants With Anxiety Depression
Run by Moon (Guangzhou) Biotechnology Co., Ltd. · NCT07331987 · Data updated 2026-11-12
This study tests whether adding probiotics to treatment can help reduce anxiety and depression symptoms in adults compared with placebo, alongside traditional therapy, and checks safety and related biological markers.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Moon (Guangzhou) Biotechnology Co., Ltd. Industry-sponsored |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | June 15, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | February 28, 2027 |
| Registry record updated | June 29, 2026 |
| Trial ID | NCT07331987 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-60 with mild-to-moderate anxiety and/or depressive symptoms meeting DSM-5 criteria and HAM-D-24 ≥8 or HAM-A-14 ≥7 at screening.
✕Probably not a fit
Individuals with severe symptoms, current use of anxiolytics/antidepressants within 2 weeks (except escitalopram) or other exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled study will enroll 60 adults with mild-to-moderate anxiety and/or depression. Participants will be assigned to probiotic, placebo, or escitalopram, with a 3-month intervention and 1-month follow-up. The researchers will measure changes in anxiety and depression scores, sleep, and safety, and will explore possible mechanisms by analyzing serum biomarkers, gut microbiota, and related metabolites. The trial aims to determine if probiotics can help improve symptoms and what biological changes accompany any improvement.
Why it matters
Potential benefit: If successful, probiotics could offer an additional or adjunctive option for improving mood and anxiety with a favorable safety profile.
How similar studies have gone: Past studies have shown mixed results; this trial contributes new evidence by including biomarker analyses and a direct comparison with escitalopram.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\) Age: 18-60 years old; Gender: male or female. * 2\) Meets the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) for a mild-to-moderate depressive or anxiety symptoms. * 3\) Hamilton Depression Rating Scale (HAM-D-24) score ≥ 8 or Hamilton Anxiety Rating Scale (HAM-A-14) score ≥ 7 at screening. * 4\) Has no used of anxiolytic or antidepressant medications (including traditional Chinese patent medicines), with the exception of Escitalopram Oxalate, within 2 weeks prior to the first dose. * 5\) For participants of childbearing potential (male or female): Must agree to use least one medically approve form of contraception (e.g., intrautering device \[IUD\], oral contraceptives, or condoms) throughout the trial. For female participants of childbearing potential: Must have a negative urine pregnancy test at screening and must be non-lactating. * 6\) The participant is willing and be able to provide written informed consent to participate in the study. Exclusion Criteria: * 1\) HAM-D-24 score ≥ 35 or HAM-A-14 score ≥ 29. * 2\) Presence of significant suicidal ideation. * 3\) History or current diagnosis of neuropsychiatric disorders such as schizophrenia or epilepsy. * 4\) History of head trauma (with loss of consciousness for \>10 minutes), other unstable major somatic diseases, or any somatic condition that could cause psychiatric symptoms. * 5\) Suspected intellectual disability. * 6\) History of alcohol or substance abuse prior to enrollment. * 7\) Cranial magnetic resonance imaging (MRI) reveals organic lesions. * 8\) Participants who are deemed unsuitable for the study by the investigator for any other reason.
Where it's running
-
The First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, Guangdong, China Recruiting
Study contacts
- Study coordinator: Baojia Huang
- Email: huangbj@moonbio.com
- Phone: 86-020-31603387
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Attachment-Based Compassion Therapy to Prevent Burnout in Spanish Healthcare Professionals
A compassion-based program is tested to see if it can help prevent burnout in Spanish doctors and nurses, compared with a relaxation program.
-
Using a weighted blanket to help cancer patients during IV therapy
A randomized study tests whether wearing a weighted blanket during IV cancer treatment reduces anxiety, stress, and depression and increases comfort compared with standard blankets.
-
Group-based ACT for psychological distress in young people
Researchers are testing whether group-based ACT helps 16-25 year olds with depression or anxiety more than the usual individual therapy.
-
Acupuncture vs Medication for Depression, Anxiety, and Sleep Issues in Chinese Adults
This study tests whether acupuncture can be as effective or more cost-efficient and environmentally friendly than usual medication for reducing depression, anxiety, and sleep problems in adults 18–65 in China.
-
Online group I-Reconstruction psychotherapy to reduce anxiety
This trial tests whether a 10-week online group course using the I-Reconstruction method can help adults with anxiety feel less anxious.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.